期刊文献+

2016年全球新药研发报告——第二部分:难忘的一年,趋势与亮点(Ⅵ)

A Report of New Drugs Research and Development in 2016—— Part Ⅱ: Trends and Highlights of an Unforgettable Year (Ⅵ)
原文传递
导出
摘要 通过敏锐的视角概述了2016年制药行业热点话题,包括传染性疾病爆发推动研发进展、孤儿药开发、管线损耗、药品价格,以及正在进行的并购和收购等。报告还分析了美国和英国最近的政治事件,以及其对新一年制药产业可能产生的影响;此外,还预测了2017年将会通过审批的新药。 This eagle's-eye overview of the drug industry in 2016 provides insight into some of last year's top stories, including disease outbreaks that drove R&D, orphan drug development, pipeline attrition, drug pricing, and the ongoing movement in mergers and acquisitions. Recent political events in the U.S. and U.K. and their potential impact on the industry in the years to come are also considered, and the new drugs that may be approved in 2017 are anticipated.
机构地区 科睿唯安
出处 《药学进展》 CAS 2017年第11期872-878,共7页 Progress in Pharmaceutical Sciences
关键词 药物批准 埃博拉 寨卡 孤儿药 药品价格 产品管线损耗 并购和收购 drug approval Ebola Zika orphan drug drag pricing pipeline attrition merger and acquisition
  • 引文网络
  • 相关文献
;
使用帮助 返回顶部